Monitoring of Serum HBV RNA, HBcrAg, HBsAg and anti-HBc Levels in Patients during Long-Term Nucleoside/Nucleotide Analogue Therapy
Antiviral Therapy2018Vol. 24(2), pp. 105–115
Citations Over TimeTop 10% of 2018 papers
Hao Liao, Yan Liu, Xiaodong Li, Jie Wang, Xiangmei Chen, Jun Zou, Qi Li, Lujie Liu, Jun Wang, Bixia Huang, Fengmin Lu, Dongping Xu
Abstract
Monitoring of HBV RNA and HBcrAg levels is useful for NA-treated patients with undetectable HBV DNA. The attainment of HBV RNA undetectability usually occurs prior to HBcrAg undetectability.
Related Papers
- → Experimental study of the inhibitory effect of gantai capsule on HBsAg and HBeAg expression(2002)1 cited
- Inhibition of HBsAg and HBeAg Expression by ASODN of Various Regions of the HBV Genome(2005)
- Inhibitory effect of extracts of the core of lithion the expression of HBsAg and HBeAg in the HepG 2.2.15 cells(2004)
- Inhibitory effect of FFYC tablets(FFYC) on expression of HBsAg and HBeAg(2004)
- Experimental Study of the Inhibitory Effect of Gantai Capsule (肝泰胶囊) on HBsAg and HBeAg Expression(2002)